M. Leroux

发表

Multi-chemothermoimmunotherapy for human colon adenocarcinoma in vitro

Z. Siddik, B. Hsi, J. Klostergaard, 1995, Cancer Chemotherapy and Pharmacology.

Sensitization of Tumor Target Cells to Cytolysis by Murine Macrophage Cytolytic Factor by Drugs Inhibiting DNA, RNA, and Protein Synthesis

J. Klostergaard, J. Souchek, M. Leroux, 1986, Journal of leukocyte biology.

[Diagnosis of disseminated intravascular coagulations].

J. Lamagnere, M. Leroux, J. Leroy, 1974, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

Efficacite comparee du volume globulaire moyen (VGM) et de la gamma-glutamyltransferase (γ-GT) serique comme tests de triage des buveurs excessifs d'alcool

J. Weill, M. Leroux, J. Bremond, 1976 .

Human Kupffer cells are cytotoxic against human colon adenocarcinoma

S. Curley, R. Pollock, J. Klostergaard, 1990, Surgery.

Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro.

M. Hung, J. Klostergaard, M. Leroux, 1991, Journal of immunology.

Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL‐2‐independent apoptosis in human prostatic adenocarcinoma cells

T. McDonnell, R. Evans, D. Farquhar, 2007, The Prostate.

MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro.

R. Evans, D. Farquhar, J. Klostergaard, 2009, Lung cancer.

[Clinical and biological observation of 3 cases of congenital afibrinogenemia in siblings].

F. Lacassie, J. Storck, M. Leroux, 1962, Hemostase.

Tumoricidal effector mechanisms of murine Bacillus Calmette-Guérin-activated macrophages: mediation of cytolysis, mitochondrial respiration inhibition, and release of intracellular iron by distinct mechanisms.

J. Klostergaard, F. Kull, M. Leroux, 1987, Cancer research.

Formulation and antitumor efficacy of liposomal-caprylated-TNF-SAM2.

G. Soma, T. Utsumi, J. Klostergaard, 1995, Cytokines and molecular therapy.

[Fibrinolysis and thrombolysis].

M. Leroux, 1965, Actualites pharmacologiques.